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Management of Ventilatory Insufficiency in Neuromuscular 
Patients Using Mechanical Ventilator Supported by the Korean 
Government 
Since 2001, financial support has been provided for all patients with neuromuscular 
disease (NMD) who require ventilatory support due to the paralysis of respiratory muscles 
in Korea. The purpose of this study was to identify ventilator usage status and 
appropriateness in these patients. We included 992 subjects with rare and incurable NMD 
registered for ventilator rental fee support. From 21 February 2011 to 17 January 2013, 
ventilator usage information, regular follow-up observation, and symptoms of chronic 
hypoventilation were surveyed by phone. Home visits were conducted for patients judged 
by an expert medical team to require medical examination. Abnormal ventilatory status 
was assessed by respiratory evaluation. Chronic respiratory insufficiency symptoms were 
reported by 169 of 992 subjects (17%), while 565 subjects (57%) did not receive regular 
respiratory evaluation. Ventilatory status was abnormal in 102 of 343 home-visit subjects 
(29.7%). Although 556 subjects (56%) reported 24-hour ventilator use, only 458 (46%) 
had an oxygen saturation monitoring device, and 305 (31%) performed an airstacking 
exercise. A management system that integrates ventilator usage monitoring, counselling 
and advice, and home visits for patients who receive ventilator support could improve the 
efficiency of the ventilator support project.
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INTRODUCTION
In cases of rare and incurable neuromuscular disease (NMD) 
showing progressive muscular weakness, hypercapnia occurs 
due to hypoventilation arising from respiratory muscle weak-
ening as the disease progresses (1-5). This ventilatory failure is 
accompanied by respiratory complications such as pneumonia 
and atelectasis, which deteriorate patients’ quality of life and 
ultimately lead to death (6,7). Applying appropriate ventilatory 
support using a ventilator and managing the ventilatory failure 
status of NMD patients through regular respiratory function 
evaluation and ventilatory status analysis can prevent respira-
tory complications and resultant death and contribute to im-
proving quality of life (6,8-12).
 To reduce the economic burden for patients with rare and 
incurable NMD due to medical expense in Korea, the govern-
ment has provided a ventilator rental fee for patients who re-
quire a ventilator due to paralysis of respiratory muscles from 
progressive muscular weakness since 2001. However, there is 
no management system to provide patients with professional 
advice and counselling on the appropriate use of ventilators 
and respiratory failure symptoms other than regular inspection 
of the devices by ventilator rental companies, and thus the ne-
cessity of improving the management of the ventilator support 
project has been suggested (13).
 As part of the Korean government’s medical expense support 
project for patients with rare and incurable disease, this study 
examined the appropriateness of ventilator usage and respira-
tory care for patients with NMD who receive a ventilator rental 
fee based on phone interviews and in-person surveys.
MATERIALS AND METHODS
Study subjects
In Korea, the following NMD are designated as ‘rare incurable 
diseases requiring support for respiratory care’: amyotrophic 
lateral sclerosis (ALS), spinal muscular atrophy (SMA), muscu-
lar dystrophy, myotonic dystrophy, congenital myopathy, mito-
chondrial myopathy, and other muscular disorders (hereditary 
ataxia, myasthenia gravis, multiple sclerosis, Charcot-Marie-
Tooth disease, Guillain-Barre syndrome, mucopolysaccharido-
sis, Pompe disease, and Creutzfeldt-Jakob disease). These pa-
tients can request ventilatory support (financial support for the 
rental cost of a portable ventilator and mechanical insufflation-
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exsufflation device) when they have more than two symptoms 
of chronic hypoventilation (fatigue, sleep disorder, nightmare, 
morning headache, anxiety, and dyspnoea) and their end-tidal 
CO2 exceeds 40 mmHg or partial pressure of carbon dioxide 
(pCO2) exceeds 45 mmHg on 2 serial examinations. The research 
subjects were 1,251 patients with rare and incurable NMD who 
had registered for ventilator rental fee support from the govern-
ment between February 2011 and April 2012. Among them, 259 
subjects (68 subjects who returned the ventilator or died, 5 who 
did not use the ventilator, 62 with incorrect contact information, 
19 who refused to take the survey, and 105 who could not be 
contacted despite more than three phone call attempts) were 
excluded, and 992 subjects were finally included. Except who 
actually did not use home mechanical ventilator (who did not 
use the ventilator and who returned the ventilator or died), a 
survey response rate was 84% (992 of 1,178).
Methods
This study involved two phone surveys and home visit surveys 
from February 21, 2011 to January 17, 2013 (first survey period: 
February 21, 2011 to December 20, 2011; second survey period: 
April 18, 2012 to January 17, 2013).
Organization of the research team
For the care and management of patients using a ventilator, a 
respiratory rehabilitation expert team, consisting of a rehabili-
tation medicine specialist, social worker, and research assistant 
nurse, was established by the Korea Centers for Disease Control 
and Prevention. The rehabilitation medicine specialist was re-
sponsible for medical consulting and advice for patients during 
phone counselling and home visits and for educating the social 
worker and nurse on the methods of respiratory failure patient 
care and evaluation. The social worker performed phone coun-
selling and surveys. The nurse performed phone counselling, 
home visits, and visit surveys.
Phone survey
Ventilator usage information, regular follow-up observation, 
and chronic respiratory insufficiency symptoms were surveyed 
by phone (Appendix 1, visible online). Ventilator usage infor-
mation included the ventilator usage period, method and the 
presence of oxygen saturation monitoring. For patients receiv-
ing home-based care at the time of survey, whether regular fol-
low-up observation was conducted through hospital visits, and 
whether respiratory evaluation was conducted at follow-ups 
was examined. For patients receiving inpatient treatment, whe-
ther regular respiratory evaluation was conducted was exam-
ined. For patients receiving home-based care who did not re-
ceive follow-up observation, the reason for this absence of fol-
low-up was also questioned. To assess the appropriateness of 
ventilator usage, the presence of fatigue, sleep disorder, night-
mares, morning headache, anxiety, and dyspnoea, which are 
symptoms of chronic respiratory insufficiency, was examined, 
with patients able to list multiple symptoms.
Home visit
After the phone survey, a home visit was conducted for 343 sub-
jects who required a medical assessment based on the judgment 
of the expert medical team (e.g., patients who had not received 
treatment for a long time and patients who had a limitation in 
prompt hospital treatment due to distance or difficulty in trans-
portation, regardless of economic condition). During the home 
visit, the presence of abnormal ventilatory status was checked 
by conducting a respiratory evaluation, and a home visit survey 
record was made (Appendix 2, visible online).
Statistical analysis
Statistical analysis was performed by using of SPSS ver. 20.0 (SPSS, 
Chicago, IL, USA). The χ2 test or the Fisher exact tests depend-
ing on individual cell size was used to compare daily use time, 
type of ventilation of each disease, as well as abnormal ventila-
tion status according to ventilator type or using time. P values 
< 0.05 were considered statistically significant.
Ethics statement
The study protocol was reviewed and approved by the institutio-
nal review board of the Gangnam Severance Hospital (IRB num-
ber 3-2015-0337). Informed consent was waived by the board. 
RESULTS
Basic characteristics of subjects
Among total 992 subjects, 436 had ALS, 260 had muscular dys-
trophy, 161 had SMA, 34 had myotonic dystrophy, 34 had con-
genital myopathy, 23 had mitochondrial myopathy, 3 had un-
specified primary muscular disorders, and 41 had other mus-
cular disorders (hereditary ataxia, myasthenia gravis, multiple 
sclerosis, Charcot-Marie-Tooth disease, Guillain-Barre syndrome, 
mucopolysaccharidosis, Pompe disease, or Creutzfeldt-Jakob 
disease). There were 658 male subjects and 334 female subjects. 
Their mean age was 41.48 ± 21.83 years. Stratified according to 
disease diagnosis, subjects with ALS had the highest mean age 
(56.62 ± 11.29 years), and subjects with congenital myopathy 
had the lowest mean age (14.88 ± 13.83 years) (Table 1).
Ventilator usage period and daily average usage time
The duration of ventilator usage is shown in Table 2. Five hun-
dred fifty-five subjects used a ventilator for 24 hours, 194 sub-
jects used it during their entire sleep and “partial daytime” (for 
a short time when necessary, less than 15 hours), 164 subjects 
used it only during sleep, and 79 subjects used it only during 
partial daytime. The proportion of full-day application was high-
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er than that of part-time application in subjects with ALS, SMA, 
and mitochondrial myopathy; in contrast, the proportion of part-
time application was higher in subjects with muscular dystro-
phy, myotonic dystrophy, and congenital myopathy. The pro-
portion of full-day application was significantly high in ALS group 
(P < 0.001), while the proportion of part-time application was 
significantly high in muscular dystrophy and congenital myop-
athy group (muscular dystrophy P < 0.001, congenital myopa-
thy P = 0.014). The proportional difference of full-time applying 
patients to part-time applying patients was not significant in 
other diseases (Table 3, Fig. 1).
Type of ventilator usage 
Invasive respiratory support (invasive positive pressure ventila-
tion, IPPV) via tracheostomy was implemented in 530 subjects 
(53.4%), and noninvasive respiratory support (NIPPV, noninva-
sive intermittent positive pressure ventilation) through a mask 
was implemented in 462 subjects (46.6%). ALS group and other 
group had significantly higher tendency of using IPPV (P < 0.001), 
whereas muscular dystrophy group had higher tendency of us-
ing NIPPV (P < 0.001) (Table 4, Fig. 2).
Table 1. Gender and age index for each disease
No. of cases by diseases 
ALS SMA
Muscular  
dystrophy
Myotonic  
dystrophy
Congenital  
myopathy
Mitochondrial 
myopathy
Other primary  
muscular disorders, 
unspecified
Others* Total
Sex Male
Female
Total
257
179
436
108
53
161
216
44
260
22
12
34
19
15
34
13
10
23
2
1
3
21
20
41
658
334
992
Age Mean
SD
56.62
11.29
27.49
19.51
26.40
12.12
37.03
17.86
14.88
13.83
19.78
19.72
32.00
28.16
39.20
22.59
41.48
21.83
ALS, amyotrophic lateral sclerosis; SMA, spinal muscular atrophy. 
*This group includes hereditary ataxia, myasthenia gravis, multiple sclerosis, Charcot-Marie-Tooth disease, Guillain-Barre syndrome, mucopolysaccharidosis, Pompe disease, 
and Creutzfeldt-Jakob disease.
Table 2. Duration of ventilator use for each disease
Duration, yr
No. of cases by
ALS SMA
Muscular  
dystrophy
Myotonic  
dystrophy
Congenital  
myopathy
Mitochondrial 
myopathy
Other primary  
muscular disorders, 
unspecified
Others* Total
> 1 157 14 39 8 3 5 3 10 239
1-3 158 31 98 12 15 9 0 16 339
3-5 67 27 54 10 10 7 0 8 183
5-7 31 28 43 3 0 2 0 4 111
7-10 20 40 19 1 5 0 0 0 85
10 < 3 21 7 0 1 0 0 3 35
Total 436 161 260 34 34 23 3 41 992
ALS, amyotrophic lateral sclerosis; SMA, spinal muscular atrophy. 
*This group includes hereditary ataxia, myasthenia gravis, multiple sclerosis, Charcot-Marie-Tooth disease, Guillain-Barre syndrome, mucopolysaccharidosis, Pompe disease, 
and Creutzfeldt-Jakob disease.
Table 3. Average time of the daily ventilator use for each disease
Duration of use
No. of cases by
ALS SMA
Muscular  
dystrophy
Myotonic 
dystrophy
Congenital 
myopathy
Mitochondrial 
myopathy
Other primary  
muscular disorders, 
unspecified
Others* Total
Full day 337   94   60 10 13 16 1 25 556
Part-time use
   At sleep
   At sleep & partial daytime
   Partial daytime
   Subtotal
  19
  46
  34
  99
  30
  28
    9
  67
  86
  87
  27
200
  9
11
  4
24
10
  9
  2
21
  3
  3
  1
  7
1
1
0
2
  6
  8
  2
16
164
193
  79
436
Total 436 161 260 34 34 23 3 41 992
ALS, amyotrophic lateral sclerosis; SMA, spinal muscular atrophy.
*This group includes hereditary ataxia, myasthenia gravis, multiple sclerosis, Charcot-Marie-Tooth disease, Guillain-Barre syndrome, mucopolysaccharidosis, Pompe disease, 
and Creutzfeldt-Jakob disease.
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Fig. 1. Percentage of time of the daily ventilator use for each disease. 
ALS, amyotrophic lateral sclerosis; SMA, spinal muscular atrophy. 
*Statistically significant P value < 0.05; †This group includes hereditary ataxia, myas-
thenia gravis, multiple sclerosis, Charcot-Marie-Tooth disease, Guillain-Barre syn-
drome, mucopolysaccharidosis, Pompe disease, and Creutzfeldt-Jakob disease.
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Table 4. Ventilator usage type for each disease
Type of ventilator
No. of cases by 
ALS SMA
Muscular  
dystrophy
Myotonic  
dystrophy
Congenital  
myopathy
Mitochondrial 
myopathy
Other primary  
muscular disorders, 
unspecified
Others* Total
IPPV 321   88   43 13 18 16 1 30 530
NIPPV 113   77 216 21 15   7 2 11 462
Total 436 161 260 34 34 23 3 41 992
ALS, amyotrophic lateral sclerosis; SMA, spinal muscular atrophy; IPPV, invasive positive pressure ventilation; NIPPV, non-invasive intermittent positive pressure ventilator.
*This group includes hereditary ataxia, myasthenia gravis, multiple sclerosis, Charcot-Marie-Tooth disease, Guillain-Barre syndrome, mucopolysaccharidosis, Pompe disease, 
and Creutzfeldt-Jakob disease.
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Fig. 2. Percentage of type of ventilator use for each disease.
IPPV, invasive positive pressure ventilation; NIPPV, non-invasive intermittent positive 
pressure ventilator; ALS, amyotrophic lateral sclerosis; SMA, spinal muscular atrophy.
*Statistically significant P value < 0.05; †This group includes hereditary ataxia, myas-
thenia gravis, multiple sclerosis, Charcot-Marie-Tooth disease, Guillain-Barre syndrome, 
mucopolysaccharidosis, Pompe disease, and Creutzfeldt-Jakob disease.
Possession of oxygen saturation monitor and 
implementation of air stacking exercise
Four hundred fifty-eight of 992 subjects (46.2%) had an oxygen 
saturation monitor, and 30.7% of subjects (n = 305) performed 
air stacking exercise. Seventy nine of 531 (14.9%) patients using 
IPPV via tracheostomy and 225 of 461 (48.8%) patients using 
NIPPV carried out air stacking exercise. 
Implementation of regular follow-up observation and 
respiratory evaluation
Among the 992 subjects, 605 subjects (61.0%) received follow-
up in outpatients, 161 subjects (16.2%) received treatment in a 
hospital and 226 subjects did not receive follow-up observation. 
Among the 605 subjects underwent follow-up observation as 
outpatients, 375 subjects received regular respiratory evalua-
tion during follow-up observation and 230 did not. Among the 
subjects receiving inpatient treatment, regular respiratory eval-
uation was implemented in only 52 of 161. In summary, 427 
(43.0%) underwent respiratory evaluation during hospital visits 
and 565 patients (57.0%) did not (Fig. 3).
Reason for the omission of follow-up observation
For the 226 subjects who did not receive follow-up observation, 
the reason for the absence of follow-up was also questioned. 
The most common reason was difficulty in travel (172 subjects, 
76.1%), followed by distance (12 subjects, 5.3%), economic dif-
ficulty (11 subjects, 4.9%), absence of a caregiver (1 subject, 0.4%), 
and other reasons (30 subjects, 13.3%) such as not feeling the 
necessity of visiting a hospital due to lack of knowledge of the 
disease.
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Presence of chronic hypoventilation symptoms
In the phone survey of 992 subjects, 169 subjects complained of 
chronic hypoventilation symptoms and reported a total of 229 
symptoms. The symptoms include fatigue (n = 7), sleep disor-
der (n = 126), nightmare (n = 2), morning headache (n = 58), 
anxiety (n = 1), and dyspnoea (n = 35).
Abnormal ventilatory status
Among the 343 subjects with home visit, 102 (29.7%) demon-
strated abnormal respiratory status (end-tidal CO2 partial pres-
sure over 40 mmHg or oxygen saturation under 94% with venti-
lator using). Among these 102 subjects, 43 demonstrated ab-
normal status of ventilation in spite of using a ventilator for 24 
hours (Fig. 4). 
 In the first survey period (February 21, 2011 to December 20, 
2011), we found 54 patients with abnormal ventilator status. 
Follow up observation of 47 subjects who could be contacted 
(excluding six subjects who passed away and one who could 
not be contacted) was done in the second survey period (April 
18, 2012 to January 17, 2013). Thirty nine patients (83%) changed 
their type of ventilator usage by visiting a hospital upon the rec-
ommendation of the research nurse following the home visit.
 Among the 343 patients, 3 patients were not evaluated due to 
ventilator malfunction. Out of 207 patients on pressure-preset 
mode, 55 patients (26.6%) were presented with respiratory fail-
ure. Out of 133 patients on volume-preset mode, 47 patients 
(35.3%) showed respiratory failure. Respiratory failure did not 
show significant difference among different ventilator preset 
mode (P = 0.091). Out of 206 patients under IPPV, 50 patients 
were presented with respiratory failure (24.3%). Meanwhile, out 
of 137 patients under NIPPV, 52 patients (38.0%) showed respi-
ratory failure. Respiratory failure was noticed significantly more 
in patients under non-invasive mode compared to those under 
invasive method (P = 0.007).
DISCUSSION
The present study reveals high rates of chronic respiratory in-
sufficiency symptoms, abnormal ventilator status, and low rates 
of regular follow-up, indicating that financial support does not 
help achieve sufficient ventilator care for NMD patients. These 
findings suggest that a new method such as the establishment 
of a home visit service is needed for the continuous care of pa-
tients for whom hospital treatment is difficult.
 In our study, overall follow-up rate of total patients was 77.2%. 
This was similar to the follow up rate of Canada National survey 
which studied whole population under home mechanical ven-
tilator use (CaNuVENT Group) (14). However, the survey results 
showed that 339 (44.3%) of the 766 subjects who received fol-
low-up observation did not receive respiratory evaluation. In-
cluding the subjects who did not receive follow-up observation, 
more than half of all subjects (n = 565, 57.0%) did not receive 
regular respiratory evaluation. Overall, 38.0% of the subjects 
who received home-based care and implemented follow-up 
observation as outpatients (230 of 605 subjects) and 32.3% of 
hospitalized subjects (52 of 161 subjects) did not receive regular 
respiratory evaluation. Thus, a high proportion of subjects did 
not receive respiratory evaluation regardless of home-based care 
or hospitalization.
 Ventilatory status of NMD patients undergoes sustained chan-
ges due to progressive weakness of respiratory muscles. Notably 
in the case of young patients, ventilation status also changes due 
to growth. The survey of home-visit subjects indicated a high 
rate of abnormal ventilatory status (29.7%). This rate is consis-
tent with previous study showing home mechanical ventilator 
failure in 30%. However, this was due to incorrect use rather 
than equipment failure. If the setting of a ventilator is based on 
a single evaluation, effective ventilatory support would be diffi-
cult and get worse as time passes. Therefore, continuous and 
regular respiratory evaluation and relevant care (e.g., changing 
the ventilator setting and usage time) are essential and the sys-
tem that checks and manages appropriate ventilator use through 
Fig. 3. A number of patients with regular follow-up observation and respiratory evalu-
ation.
f/u, follow-up; +, yes; -, no.
Total
992
Outpatient f/u
Respiratory 
evaluation
Respiratory 
evaluation
Respiratory evaluation
427 patients
No f/uInpatient f/u
605
+
- -
+
161
230 109 226
No respiratory evaluation
565 patients
375 52
Fig. 4. Ventilatory status of the subjects visited at home.
343
Ventilatory 
status
Ventilatory 
status
Daily  
usage time
Full time use
Normal
Abnormal
Abnormal
Normal
Part-time use
200 143
43 59
Abnormal ventilatory status
157
84
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regular respiratory evaluation, rather than simply prescribing a 
ventilator, is needed.
 Survey results indicated that 556 of the total 992 subjects (56%) 
used a ventilator for 24 hours, indicating high dependence. Ox-
ygen saturation monitoring, which can detect symptoms of a 
ventilator problem, is especially important when ventilator de-
pendence is high. However, only 458 subjects (46%) had an ox-
ygen saturation monitoring device. In addition, air stacking ex-
ercise is known to reduce respiratory complications by signifi-
cantly increasing maximal insufflation capacity and assisted 
peak cough flow (15,16). It also improves the quality of life of 
terminal NMD patients who use a noninvasive ventilator by de-
laying the time to conversion to an invasive ventilator through 
tracheostomy or intubation. However, this exercise was imple-
mented by only 305 subjects (31%). Thus, it appears that educa-
tion on the importance of oxygen saturation monitoring and air 
stacking exercise and additional care for patients were insuffi-
cient, suggesting that a management system that can provide 
advice and counselling on respiratory failure symptoms as well 
as the use and management of a ventilator is required.
 Among the 992 subjects who participated in this study, 831 
(83.8%) received home-based care, and 231 (23.3%) had used a 
ventilator for more than 5 years. This finding was similar to pre-
vious reports on long term use of ventilator among patients with 
neuromuscular diseases (17,18). For most NMD patients who 
require long-term respiratory support, ventilator support can 
improve the quality of life of patients and caregivers and reduce 
unnecessary medical expense, because patients need not re-
ceive inpatient treatment simply for the use of a ventilator. How-
ever, the results of this study indicate that sufficient respiratory 
care was not achieved simply through the voluntary hospital 
visits of patients. We recommended the subjects with abnormal 
ventilatory status to take a proper care for appropriate use of 
the ventilator when we found them through the home visit in 
the first survey period. In the second period, we checked them 
again. Consequently, 83% of them changed their ventilator set-
ting appropriately by visiting a hospital. In other words, simply 
providing economic support for ventilator usage was insufficient 
for achieving appropriate respiration in patients, while a com-
prehensive management system could ensure that more patients 
receive proper treatment.
 The percentage of patients under IPPV varied among differ-
ent countries. The percentage of patients under IPPV in Eurovent 
study was 24% and was only 18% in Sweden, whereas in Ger-
many it was 50%, and 35% in Denmark (18). In Australia and 
New Zealand, the percentage was only 3% (19). In this study, 
the percentage of patients under IPPV was 53.4%, higher than 
in any other previous studies. Eurovent study explains that these 
differences most likely reflect local and national practices. Add-
ing to this, we suggest that the different proportion of neuromus-
cular diseases among countries may affect the different percent-
age of patients under IPPV. Patients with ALS showed higher 
proportion of those under IPPV, consistent with findings in the 
study from CaNuVENT group (14). Unlike other neuromuscu-
lar diseases, bulbar dysfunction develops in ALS as the disease 
progresses. Once reaching the critical level, tracheostomy is in-
evitable for non-invasive muscle aids become inadequate (20, 
21). On the other hand, patients with muscular dystrophy re-
vealed higher proportion of those under NIPPV. This is also con-
sistent with previous studies, which have already shown that 
tracheostomy is unnecessary in these patients (22,23). Since 
our study shows higher proportion of ALS than other neuro-
muscular diseases, we could guess that the proportion of pa-
tients under IPPV is high as well. 
 We would also like to stress on importance of frequent pul-
monary evaluation. Higher tendency of respiratory failure was 
noticed among patients under NIPPV compared to those under 
IPPV in this study. Ironically, NIPPV is known to enable oral diet, 
speech, and improve quality of life (24,25). Thus we recommend 
getting more frequent monitoring when maintaining NIPPV. 
 The major limitation of this study is that not all patients were 
evaluated at home. However, survey response rate was 84%, sim-
ilar to that of previous studies. It was 79% in Eurovent survey (18), 
89% in CaNuVENT survey (14), and in 82% in Australia and New 
Zealand (19). Unlike previous studies, however, this study is uni-
que in that 1/3 of the patients were visited and evaluated by med-
ical team. 
 In the future, the effects of the operation of the central man-
agement centre on patient status should be surveyed based on 
the currently established cohort. An efficient method for improv-
ing patients’ hospital access also requires further study.
 In conclusion, the efficiency of the ventilator support project 
could be maximized, and the social and medical cost reduced, 
by the implementation of a management system that can link 
monitoring of the appropriateness of ventilator usage, counsel-
ling and advice, and home visits for patients who receive venti-
lator support to establish proper treatment.
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